Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Altria Group Inc (MO) vs Koninklijke Philips NV (PHG) Price & Performance

Altria Group IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Koninklijke Philips NV — how do they compare? Altria Group Inc trades at $68.06 (market cap $113.83B), while Koninklijke Philips NV trades at $25 (market cap $24.84B). The key difference: Altria Group Inc is far larger — about 4.6× Koninklijke Philips NV's market cap, and Altria Group Inc pays the higher dividend (6.51%). Which is the better fit depends on your goals.

MOPHG
Market Cap
$113.83B$24.84B
Sector
Consumer StaplesHealth
52-Week High
$74.92$32.91
52-Week Low
$54.72$25.02
Enterprise Value
$136.04B$31.44B
Dividend Yield
6.51%4.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

Altria Group (MO) trades at $68.18, down 1.02% on the day, with a bearish technical signal from moving averages and neutral oscillators. The stock offers a high dividend yield of 6.45% following its 61st annual increase. Recent earnings show mixed quarterly results, with Q1 2026 beating expectations but Q2 2026 missing. Revenue remains stable around $20.1 billion (2025), with strong profitability margins, though net income declined to $6.95 billion in 2025 from $11.3 billion in 2024. Analyst consensus is bullish with a $68.50 price target.

MO presents a value opportunity with a low P/E of 14.35 and robust cash flows supporting dividends, but faces risks from regulatory lawsuits, declining cigarette volumes, and high debt levels. The stock's appeal hinges on dividend sustainability amid secular challenges in the tobacco industry.

Koninklijke Philips NV

PHG trades at $25.29, down 2.32% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $0.57 versus $0.40 expected, continuing a trend of profitability after a turnaround from losses in prior years. Recent news highlights product launches in health technology and a $33.7 million award for AI-enabled stroke care (Business Wire, 2026-08-26).

The outlook is mixed: fundamentals show improving margins and cash flow, but technical indicators and a majority hold analyst rating suggest near-term caution. Key risks include competitive pressures and execution of growth initiatives, while institutional buying activity indicates underlying confidence.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG